| Literature DB >> 25963224 |
Lauren Chalmers1, Jessica Cross1, Cindy S Chu1, Aung Pyae Phyo1, Margreet Trip1, Clare Ling1, Verena Carrara1, Wanitda Watthanaworawit1, Lily Keereecharoen1, Borimas Hanboonkunupakarn2, François Nosten1,2,3, Rose McGready1,2,3.
Abstract
OBJECTIVE: Published literature from resource-limited settings is infrequent, although urinary tract infections (UTI) are a common cause of outpatient presentation and antibiotic use. Point-of-care test (POCT) interpretation relates to antibiotic use and antibiotic resistance. We aimed to assess the diagnostic accuracy of POCT and their role in UTI antibiotic stewardship.Entities:
Keywords: BLSE; antibiotic resistance; betalactamasas de amplio espectro; extended-spectrum β-lactamase; infección del tracto urinario; infection des voies urinaires; point-of-care tests; pruebas de diagnóstico en el punto de atención; resistencia a antibióticos; résistance aux antibiotiques; tests au point des soins; urinary tract infection
Mesh:
Substances:
Year: 2015 PMID: 25963224 PMCID: PMC4758398 DOI: 10.1111/tmi.12541
Source DB: PubMed Journal: Trop Med Int Health ISSN: 1360-2276 Impact factor: 2.622
Figure 1Samples for analysis of point‐of‐care tests and culture.
Antimicrobial susceptibility of E. coli organisms in non‐pregnant adults on the Thailand–Myanmar border, 2013–2014 (n = 67)
| Resistant % ( | Intermediate % ( | Sensitive % ( | |
|---|---|---|---|
| Ampicillin | 70.1 (49) | 4.5 (3) | 25.4 (17) |
| Ceftriaxone | 20.9 (14) | 0 (0) | 79.1 (53) |
| Co‐amoxiclav | 7.5 (5) | 31.3 (21) | 61.2 (41) |
| Cotrimoxazole | 62.7 (42) | 0 (0) | 37.3 (25) |
| Ciprofloxacin | 20.9 (14) | 0 (0) | 79.1 (53) |
| Gentamicin | 20.9 (14) | 0 (0) | 79.1 (53) |
| Nitrofurantoin | 0 (0) | 0 (0) | 100 (67) |
| Meropenem | 0 (0) | 0 (0) | 100 (67) |
Sensitivity and specificity of point‐of‐care tests to urine culture results in non‐pregnant adults
|
| Sensitivity % ( | Specificity % ( | PPV % ( | NPV % ( | DOR | ||
|---|---|---|---|---|---|---|---|
| Leucocyte esterase ≥1 | All patients | 185 | 94 (72/77) | 49 (53/108) | 57 (72/127) | 91 (53/58) | 13.88 |
| UTI | 97 | 94 (65/69) | 11 (3/28) | 72 (65/90) | 43 (3/7) | 1.95 | |
| Nitrite positive | All patients | 185 | 48 (37/77) | 94 (101/108) | 84 (37/44) | 72 (101/141) | 13.35 |
| UTI | 97 | 52 (36/69) | 79 (22/28) | 73 (36/42) | 4 (22/55) | 4.00 | |
| Leucocyte esterase ≥1 ± nitrite positive | All patients | 185 | 99 (76/77) | 47 (51/108) | 57 (76/133) | 98 (51/52) | 68.00 |
| UTI | 97 | 100 (69/69) | 7 (2/28) | 73 (69/95) | 100 (2/2) | n/a | |
| Blood ≥1 and protein ≥1 | All patients | 185 | 30 (23/77) | 90 (97/108) | 68 (23/34) | 64 (97/151) | 3.76 |
| UTI | 97 | 32 (22/69) | 93 (26/28) | 92 (22/24) | 36 (26/73) | 6.09 | |
| Microscopy WBC ≥10/HPF, epithelial cells <5/HPF, bacteria ≥1/HPF | All patients | 185 | 57 (44/77) | 89 (96/108) | 79 (44/56) | 74 (96/129) | 10.67 |
| UTI | 97 | 64 (44/69) | 57 (16/28) | 79 (44/56) | 39 (16/41) | 2.35 | |
| Microscopy and/or dipstick positive | All patients | 185 | 99 (76/77) | 47 (51/108) | 57 (76/133) | 98 (51/52) | 68.00 |
| UTI | 97 | 100 (69/69) | 7 (2/28) | 73 (69/95) | 100 (2/2) | n/a | |
| Microscopy and dipstick positive | All patients | 109 | 98 (44/45) | 81 (52/64) | 79 (44/56) | 98 (52/53) | 190.67 |
| UTI | 58 | 100 (44/44) | 14 (2/14) | 79 (44/56) | 100 (2/2) | n/a |
PPV, positive predictive value, NPV, negative predictive value, DOR, diagnostic odds ratio which is not available (n/a) when sensitivity = 100.
Includes diagnosis of UTI and pyelonephritis.
Figure 2Hypothetical proportions (%) of over and under treatment based on retrospective analysis of point‐of‐care testing compared to urine culture.
Antimicrobial susceptibility of isolated organisms compared to prescribed antimicrobial in non‐pregnant adults
| Antimicrobial prescribed | Antimicrobial susceptibility | ||
|---|---|---|---|
| Resistant % ( | Intermediate % ( | Sensitive % ( | |
| Ciprofloxacin | 9.4 (3) | 0 (0) | 90.6 (29) |
| Ceftriaxone | 28.6 (2) | 0 (0) | 71.4 (5) |
| Nitrofurantoin | 3.4 (1) | 3.4 (1) | 86.2 (25) |
Total is 66 (not 69 as reported earlier in results) as one sample report failed to include antibiotic susceptibility, and in two samples, susceptibilities were not undertaken for Burkholderia cepacia and Salmonella sp. according to standard operating procedures.